The association between statin use and age related maculopathy.
about
Statins for age-related macular degenerationStatins for age-related macular degenerationStatins for age-related macular degenerationDifferential gene expression in anatomical compartments of the human eye.Statins for age-related macular degenerationDyslipidemia and eye diseases in the adult Chinese population: the Beijing eye studyElevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor studyCholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort studyRetinal haemodynamics in patients with age-related macular degeneration.Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration.A review of drug options in age-related macular degeneration therapy and potential new agents.Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary studyDiabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis.Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.Pleiotropic effects of the HMG-CoA reductase inhibitorsLipids, lipoproteins, and age-related macular degenerationAssociation between statin use and uveitis: results from the Pacific Ocular Inflammation studyThe relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study.A case control study of age related macular degeneration and use of statins.The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9The association between statin use and risk of age-related macular degeneration.Statin use and ocular inflammatory disease risk.New therapeutic targets in atrophic age-related macular degeneration.Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies.Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS)A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD.Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.Role of statins in the development and progression of age-related macular degeneration.Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008.The controversy over the association between statins use and progression of age-related macular degeneration: a mini review.Do statins have a role in the prevention of age-related macular degeneration?Role of Lipids in Retinal Vascular and Macular Disorders.Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels.Neuroprotective Effects of Low-Dose Statins in the Retinal Ultrastructure of Hypercholesterolemic RabbitsMouse models may provide new insight into the relation between cholesterol and age related macular degeneration.Update of the vascular model of AMD.Pitavastatin: protection against neuronal retinal damage induced by ischemia-reperfusion injury in rats.
P2860
Q24188161-5BD69A97-8EA0-4AD1-A9AF-B7CEBE79D588Q24201178-1589A0F9-5EBF-42B6-8201-B1099C06B058Q24240102-B5C1CA28-ED19-4445-819D-15111F7AC854Q24814005-62691153-BCE2-412E-8511-D978A1EAB2B9Q26470515-C52687A0-7722-48AD-99B6-83172FE03C50Q28482265-064FB638-D646-4C7A-9D37-53D78624A3C3Q28540642-5C907B33-F431-45AD-872E-8EF3A4AD0C46Q28740349-107C112F-356F-42A7-A521-B2F1AE6A16B7Q30854374-532F4C41-5091-426C-B48C-E735E47888D7Q33212693-740EE367-605E-4034-BE6C-F202F1804F71Q33263803-195A8AB7-66F5-44CC-B13A-D75B7006E9E0Q33616519-FA0CA5F7-6461-45D2-9256-1B7F854969E5Q34216036-EF7255BB-3FC2-4D37-B83D-536A773FE7FDQ34395891-5A1CF7BE-8DF2-4746-827E-9889703B1E5FQ34411415-569F71B0-787A-4634-9B8F-D88521686792Q34894749-97671E48-3284-4E26-94E8-79DFD02B8D54Q35138088-0722681A-C92E-401C-AE59-ABA9D01162B1Q35181364-63469D76-7FE2-4790-8DE2-2FC68FD68CBCQ35593582-7A1C5A85-6AA3-4E12-8C13-41B909EC3527Q35593614-59989902-0037-437E-AA8C-6A9F4CDE9F5DQ36315753-D39524C7-9F70-4567-8F48-2C27B18436AEQ36367171-782F8D73-0713-4713-8472-4D001A81F5E4Q36707183-69C65A09-2944-4496-851E-4D125A99DBB7Q36804427-728EAD59-0CCF-46CE-8CA9-45075A9D8453Q37045695-604988A4-44B6-4FDF-8463-E90486FBA9A7Q37192985-1549FDCA-2695-4A4A-A13F-AF0380FBF13BQ37311007-14DCEF13-7B91-4450-B849-FE93F2F6EDB2Q37456394-4D20FDA8-BB26-4B15-B08B-CCD168EB66F0Q37612307-BADE20C1-970F-43F1-81D2-8D29971D463CQ37697907-4B381557-40C0-4F20-8653-D64E72B0C1CAQ37780449-55345A06-F691-43CA-B7EA-E632E640A61AQ38083044-6C9EF9A3-C037-438A-93ED-A4524F4C8D96Q39114176-F49CC70B-2F0E-46A8-A6D4-56D0C2DEE8A0Q39685580-559AD620-ACFD-47CC-BF9F-AD6E0F3ACB99Q40986751-2CE080B5-9A53-4A6C-9F63-65318533ED1EQ43006634-B3EB3980-6D47-464A-AD91-EC9B8C89DE94Q43008063-3D8AB58A-1955-4B03-BED6-EF40EC23CFFAQ46890463-62C9EE9D-FA8B-4100-91B6-16718616F71E
P2860
The association between statin use and age related maculopathy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The association between statin use and age related maculopathy.
@ast
The association between statin use and age related maculopathy.
@en
type
label
The association between statin use and age related maculopathy.
@ast
The association between statin use and age related maculopathy.
@en
prefLabel
The association between statin use and age related maculopathy.
@ast
The association between statin use and age related maculopathy.
@en
P2093
P2860
P356
P1476
The association between statin use and age related maculopathy.
@en
P2093
P2860
P304
P356
10.1136/BJO.87.9.1121
P407
P577
2003-09-01T00:00:00Z